ZNF804A Products

ZNF804A Antibody
ZNF804A Antibody
Species: Hu
Applications: WB, IP
Host: Rabbit Polyclonal


Chimera RNA interference (chimera RNAi) is process by which small interfering RNA/DNA chimera triggers the destruction of mRNA for the original gene. The discovery work, design, and application of chimera RNAi has been pioneered by Professor Kaoru Saigo and Dr. Kumiko Ui-Tei at the University of Tokyo. Chimera RNAi has many advantages over the conventional siRNAs. First, it has been demonstrated to have reliable knock-down for over 10,000 human genes. Because the human genome is composed of an intricate, genetic network, chimera RNAi's unique design has successfully obviated the off-target effects including microRNA-based influence. Another advantage of the chimera RNAi technology is its effectiveness at low concentrations (0.5nM to 5nM); only mRNA is destroyed so genomic genes are not affected. Finally, having both the sense and anti-sense strands consisting RNA/DNA chimera, it offers much greater compound stability for streamlining in vitro and in vivo assays and applications while minimizing interferon induction and other adverse reactions.


Entrez Human
Product By Gene ID 91752
Alternate Names
  • C2orf10
  • ZNF804A zinc finger protein 804A

Pathways for ZNF804A

View related products by pathway and learn more about each of the pathways below.

Cell Adhesion
Brain Development
Dna Methylation

PTMs for ZNF804A

Learn more about PTMs related to ZNF804A.


Bioinformatics Tool for ZNF804A

Discover related pathways, diseases and genes to ZNF804A. Need help? Read the Bioinformatics Tool Guide for instructions on using this tool.
Vizit™, under license from BioVista Inc.